8-Bromo-3-methyl-xanthine: Comprehensive User Guide
Table of Contents
- 1. Product Specifications & Comparative Analysis
- 2. Detailed Applications in Research & Industry
- 3. Operational Protocols & Best Practices
- 4. Case Studies: Experimental Implementations
- 5. Verified Client Success Stories
- 6. Request Customized Quotation
1. Product Specifications & Comparative Analysis
| Parameter | 8-Bromo-3-methyl-xanthine | Standard Xanthine Derivatives |
|---|---|---|
| Chemical Formula | C6H7BrN4O2 | Varies by compound |
| Molecular Weight | 271.05 g/mol | 200-300 g/mol range |
| CAS Number | 118290-26-9 | N/A |
| Purity Grade | ≥98% (HPLC) | Typically 95-97% |
| Solubility | DMSO: 50 mg/mL Methanol: 20 mg/mL |
Variable solubility profiles |
2. Detailed Applications in Research & Industry
Core Functional Properties
- Potent phosphodiesterase (PDE) inhibitor
- Selective adenosine receptor antagonist
- cAMP level modulator in cellular systems
Primary Use Cases
- Neurological research: Parkinson’s disease models
- Inflammation studies: Asthma pathogenesis analysis
- Metabolic research: Lipid regulation mechanisms
- Oncology: Tumor microenvironment modulation
3. Operational Protocols & Best Practices
Recommended Workflow
- Reconstitution: Use anhydrous DMSO at 10 mM concentration
- Storage: -20°C in dark, dry environment
- Dosage Range: 10-100 μM (cell culture applications)
- Control Setup: Always include vehicle control group
4. Case Studies: Experimental Implementations
Case 1: Asthma Research Model
- Application: Inhibition of airway inflammation
- Result: 62% reduction in inflammatory markers
- Protocol: Daily 50 μM dosage for 7 days
Case 2: Neuroprotective Studies
- Application: Dopaminergic neuron protection
- Result: 40% increase in neuron survival rate
- Protocol: Acute 100 μM treatment post-injury
5. Verified Client Success Stories
Client 1: University Research Laboratory
- Project: Alzheimer’s disease therapeutic screening
- Usage: 15g over 6-month period
- Outcome: Identified novel therapeutic pathway
- Publication: Journal of Neurochemistry 2023
Client 2: Pharmaceutical Development Company
- Application: COPD drug candidate optimization
- Consumption: 2kg bulk order for preclinical trials
- Achievement: Accelerated IND submission timeline
6. Request Customized Quotation
Contact our technical specialists for:
- Bulk pricing (100g+ quantities)
- Custom synthesis services
- Technical documentation packages
Email: info@vivalr.com
Phone: (86) 15866781826


评论
目前还没有评论。